Modulation of cancer cell line differentiation: A neglected proteomic analysis with potential implications in pathophysiology, diagnosis, prognosis, and therapy of cancer

Proteomics - Clinical Applications

Volumn 2, Issue 2, 2008, Pages 229-237

  Scatena, Roberto ^a   Bottoni, Patrizia ^a   Giardina, Bruno ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Biomarkers; Cancer; Cell differentiation; Diagnostics; Oncoproteomics

Indexed keywords

ANTIOXIDANT; ARGINYLGLYCYLASPARTIC ACID; ARSENIC TRIOXIDE; BCR ABL PROTEIN; BUTYRIC ACID; CATHEPSIN D; ESTRADIOL; HISTONE DEACETYLASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; RETINOIC ACID; RETINOID DERIVATIVE; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA; VORINOSTAT;

APOPTOSIS; BREAST CANCER; CANCER CELL CULTURE; CANCER GRADING; CANCER INHIBITION; CANCER REGRESSION; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; COLON CARCINOMA; CYTOLOGY; EXPERIMENTAL MODEL; HUMAN; IN VITRO STUDY; LEUKEMIA; LIVER CELL CARCINOMA; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MODULATION; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; NEUROBLASTOMA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEOMICS; REVIEW;

EID: 39649090972     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780014     Document Type: Review

References (59)

1. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J. et al., Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359, 572-577.
2. Zhu, W., Wang, X., Ma, Y., Rao, M. et al., Detection of cancer-specific markers amid massive mass spectral data. Proc. Natl. Acad. Sci. USA 2003, 100, 14666-14671.
3. Feng, J. T., Shang, S., Beretta, L., Proteomics for the early detection and treatment of hepatocellular carcinoma. Oncogene 2006, 25, 3810-3817.
4. Zhou, G., Li, H., DeCamp, D., Chen, S., 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell. Proteomics 2002, 2, 117-124.
5. Engwegen, J. Y., Gast, M. C., Schellens, J. H., Beijnen, J. H., Clinical proteomics: Searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol. Sci. 2006, 5, 251-259.
6. Azad, N. S., Rasool, N., Annunziata, C. M., Minasian, L., Proteomics in clinical trials and practice: Present uses and future promise. Mol. Cell. Proteomics 2006, 10, 1819-1829.
7. Dijkstra, M., Vonk, R. J., Jansen, R. C., SELDI-TOF mass spectra: A view on sources of variation. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 847, 12-23.
8. Villanueva, J., Philip, J., Chaparro, C. A., Li, Y., Correcting common errors in identifying cancer-specific serum peptide signatures. J. Proteome Res. 2005, 4, 1060-1072.
9. Irish, J. M., Kotecha, N., Nolan, G. P., Mapping normal and cancer cell signalling networks: Towards single-cell proteomics. Nat. Rev. Cancer 2006, 2, 146-155.
10. Cho, W. C., Contribution of oncoproteomics to cancer biomarker discovery. Mol. Cancer 2007, 6, 25.
11. Qumsiyeh, M. B., Li, P., Molecular biology of cancer: Cytogenetics, in: De Vita, V. T., Hellmann, S., Rosenberg, S. A. (Eds.), Cancer: Principles and Practice of Oncology, 6th Edn., J. B. Lippincott Company, Philadelphia 2001, pp. 77-90.
12. Melle, C., Kaufmann, R., Hommann, M., Bleul, A. et al., Proteomic profiling in microdissected hepatocellular carcinoma tissue using ProteinChip technology. Int. J. Oncol. 2004, 4, 885-891.
13. Espina, V., Wulfkuhle, J. D., Calvert, V. S., VanMeter, A. et al., Laser-capture microdissection. Nat. Protoc. 2006, 1, 586-603.
14. Herrera, G., Diaz, L., Martinez-Romero, A., Gomes, A. et al., Cytomics: A multiparametric, dynamic approach to cell research. Toxicol. In Vitro 2007, 21, 176-182.
15. Santamaria, E., Munoz, J., Fernandez-Irigoyen, J., Prieto, J., Corrales, F. J., Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics. Liver Int. 2007, 2, 163-173.
16. Navakauskiene, R., Treigyte, G., Gineitis, A., Magnusson, K. E., Identification of apoptotic tyrosine-phosphorylated proteins after etoposide or retinoic acid treatment. Proteomics 2004, 4, 1029-1041.
17. Barati, M. T., Rane, M. J., Klein, J. B., McLeish, K. R., A proteomic screen identified stress-induced chaperone proteins as targets of Akt phosphorylation in mesangial cells. J. Proteome Res. 2006, 7, 1636-1646.
18. Kim, Y. M., Song, E. J., Seo, J., Kim, H. J., Lee, K. J., Proteomic analysis of tyrosine phosphorylations in vascular endothelial growth factor- and reactive oxygen species-mediated signaling pathway. J. Proteome Res. 2007, 2, 593-601.
19. de Graauw, M., Hensbergen, P., van de Water, B., Phosphoproteomic analysis of cellular signaling. Electrophoresis 2006, 13, 2676-2686.
20. Warrel, R. P., Differentiation agents, in: De Vita, V. T., Hellmann, S., Rosenberg, S. A. (Eds.), Cancer: Principles and Practice of Oncology, 6th Edn., J. B. Lippincott Company, Philadelphia 2001, pp. 489-494.
21. Calleja, E. M., Warrell, R. P., Jr., Differentiating agents in pediatric malignancies: All-trans-retinoic acid and arsenic in acute promyelocytic leukemia. Curr. Oncol. Rep. 2000, 2, 519-523.
22. Juan, H. F., Lin, J. Y., Chang, W. H., Wu, C. Y. et al., Biomic study of human myeloid leukemia cells differentiation to macrophages using DNA array, proteomic, and bioinformatic analytical methods. Electrophoresis 2002, 15, 2490-2504.
23. Harris, M. N., Ozpolat, B., Abdi, F., Gu, S. et al., Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia. Blood 2004, 104, 1314-1323.
24. Wang, D., Jensen, R., Gendeh, G., Williams, K., Pallavicini, M. G., Proteome and transcriptome analysis of retinoic acid-induced differentiation of human acute promyelocytic leukemia cells, NB4. J. Proteome Res. 2004, 3, 627-635.
25. Zheng, P. Z., Wang, K. K., Zhang, Q. Y., Huang, Q. H., Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 2005, 102, 7653-7658.
26. Grebenova, D., Kuzelova, K., Pluskalova, M., Peslova, G. et al., The proteomic study of sodium butyrate antiproliferative/ cytodifferentiation effects on K562 cells. Blood Cells Mol. Dis. 2006, 3, 210-217.
27. Seow, T. K., Liang, R. C., Leow, C. K., Chung, M. C., Hepatocellular carcinoma: From bedside to proteomics. Proteomics 2001, 10, 1249-1263.
28. Wu, N., Zhang, W., Yang, Y., Liang, Y. L. et al., Profilin 1 obtained by proteomic analysis in all-trans retinoic acid-treated hepatocarcinoma cell lines is involved in inhibition of cell proliferation and migration. Proteomics 2006, 22, 6096-6106.
29. Cui, J. F., Liu, Y. K., Pari, B. S., Song, H. Y. et al., Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins. J. Cancer Res. Clin. Oncol. 2004, 10, 615-622.
30. Dai, Z., Liu, Y. K., Cui, J. F., Shen, H. L., Identification and analysis of altered alphal,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis. Proteomics 2006, 21, 5857-5867.
31. Ang, I. L., Poon, T. C., Lai, P. B., Chan, A. T. et al., Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: A glycoproteomic approach. J. Proteome Res. 2006, 10, 2691-2700.
32. Wang, Y., He, Q. Y., Chen, H., Chiu, J. F., Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: Proteomic characterization. Exp. Cell Res. 2007, 313, 357-368.
33. Malorni, L., Cacace, G., Cuccurullo, M., Pocsfalvi, G. et al., Proteomic analysis of MCF-7 breast cancer cell line exposed to mitogenic concentration of 17beta-estradiol. Proteomics 2006, 22, 5973-5982.
34. Somiari, R. I., Sullivan, A., Russell, S., Somiari, S. et al., High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics 2003, 3, 1863-1873.
35. Kim, S. H., Lee, S. U., Kim, M. H., Kim, B. T., et al., Mitogenic estrogen metabolites alter the expression of 17beta-estradiol-regulated proteins including heat shock proteins in human MCF-7 breast cancer cells. Mol. Cells 2005, 20, 378-384.
36. Juan, H. F., Wang, I. H., Huang, T. C., Li, J. J. et al., Proteomics analysis of a novel compound: Cyclic RGD in breast carcinoma cell line MCF-7. Proteomics 2006, 10, 2991-3000.
37. Liu, Y., Chen, Q., Zhang, J. T., Tumor suppressor gene 14-3-3sigma is down-regulated whereas the proto-oncogene translation elongation factor 1delta is up-regulated in nonsmall cell lung cancers as identified by proteomic profiling. J. Proteome Res. 2004, 3, 728-735.
38. Keshamouni, V. G., Michailidis, G., Grasso, C. S., Anthwal, S., Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J. Proteome Res. 2006, 5, 1143-1154.
39. Lou, X., Xiao, T., Zhao, K., Wang, H. et al., Cathepsin D is secreted from M-BE cells: Its potential role as a biomarker of lung cancer. J. Proteome Res. 2007, 6, 1083-1092.
40. Oh, J. E., Karlmark Raja, K., Shin, J. H., Hengstschlager, M. et al., The neuronal differentiation process involves a series of antioxidant proteins. Amino Acids 2005, 3, 273-282.
41. Oh, J. E., Karlmark Raja, K., Shin, J. H., Pollak, A. et al., Cytoskeleton changes following differentiation of N1E-115 neuroblastoma cell line. Amino Acids 2006, 3, 289-298.
42. Oh, J. E., Freilinger, A., Gelpi, E., Pollak, A. et al., Proteins involved in neuronal differentiation of neuroblastoma cell line N1E-115. Electrophoresis 2007, 28, 2009-2017.
43. Stierum, R., Gaspari, M., Dominels, Y., Ouatas, T. et al., Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2. Biochim. Biophys. Acta 2003, 1650, 73-91.
44. Turck, N., Richert, S., Gendry, P., Stutzmann, J. et al., Proteomic analysis of nuclear proteins from proliferative and differentiated human colonic intestinal epithelial cells. Proteomics 2004, 1, 93-105.
45. Pshezhetsky, A. V., Fedjaev, M., Ashmarina, L., Mazur, A. et al., Subcellular proteomics of cell differentiation: Quantitative analysis of the plasma membrane proteome of Caco-2 cells. Proteomics 2007, 13, 2201-2215.
46. Spreafico, A., Freudiani, B., Capperucci, C., Chellini, F. et al., A proteomic study on human osteoblastic cells proliferation and differentiation. Proteomics 2006, 12, 3520-3532.
47. Li, H., Desouza, L. V., Ghanny, S., Li, W. et al., Identification of candidate biomarker proteins released by human endometrial and cervical cancer cells using two-dimensional liquid chromatography/tandem mass spectrometry. J. Proteome Res. 2007, 6, 2615-2622.
48. Sardana, G., Marshall, J., Diamandis, E. P., Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium. Clin. Chem. 2007, 53, 429-437.
49. Hayashi, E., Kuramitsu, Y., Okada, F., Fujimoto, M. et al., Proteomic profiling for cancer progression: Differential display analysis for the expression of intracellular proteins between regressive and progressive cancer cell lines. Proteomics 2005, 4, 1024-1032.
50. Wu, C. C., Chien, K. Y., Tsang, N. M., Chang, K. P. et al., Cancer cell-secreted proteomes as a basis for searching potential tumor markers: Nasopharyngeal carcinoma as a model. Proteomics 2005, 12, 3173-3182.
51. Zhou, G., Li, H., DeCamp, D., Chen, S. et al., 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell. Proteomics 2002, 2, 117-124.
52. Jordan, C. T., Guzman, M. L., Noble, M., Cancer stem cells. N. Engl. J. Med. 2006, 355, 1253-1261.
53. Baharvand, H., Fathi, A., van Hoof, D., Salekdeh, G. H., Concise review: Trends in stem cell proteomics. Stem Cells 2007, 25, 1888-1903.
54. Van Hoof, D., Passier, R., Ward-Van Oostwaard, D., Pinkse, M. W., A quest for human and mouse embryonic stem cell-specific proteins. Mol. Cell. Proteomics 2006, 5, 1261-1273.
55. Baharvand, H., Hajheidari, M., Ashtiani, S. K., Salekdeh, G. H., Proteomic signature of human embryonic stem cells. Proteomics 2006, 6, 3544-3549.
56. Feldmann, R. E., Jr., Bieback, K., Maurer, M. H., Kalenka, A. et al., Stem cell proteomes: A profile of human mesenchymal stem cells derived from umbilical cord blood. Electrophoresis 2005, 26, 2749-2758.
57. Salasznyk, R. M., Westcott, A. M., Klees, R. F., Ward, D. F. et al., Comparing the protein expression profiles of human mesenchymal stem cells and human osteoblasts using gene ontologies. Stem Cells Dev. 2005, 14, 354-366.
58. Hoffrogge, R., Mikkat, S., Scharf, C., Beyer, S. et al., 2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM). Proteomics 2006, 6, 1833-1847.
59. Josephson, R., Ording, C. J., Liu, Y., Shin, S. et al., Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research. Stem Cells 2007, 25, 437-446.